These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 23227878)

  • 1. Sequence-based in silico analysis of well studied hepatitis C virus epitopes and their variants in other genotypes (particularly genotype 5a) against South African human leukocyte antigen backgrounds.
    Prabdial-Sing N; Puren AJ; Bowyer SM
    BMC Immunol; 2012 Dec; 13():67. PubMed ID: 23227878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of T-cell epitopes of hepatitis C virus genotype 5a.
    Gededzha MP; Mphahlele MJ; Selabe SG
    Virol J; 2014 Nov; 11():187. PubMed ID: 25380768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-silico analysis of putative HCV epitopes against Pakistani human leukocyte antigen background: An approach towards development of future vaccines for Pakistani population.
    Ashraf NM; Bilal M; Mahmood MS; Hussain A; Mehboob MZ
    Infect Genet Evol; 2016 Sep; 43():58-66. PubMed ID: 27166094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally occurring resistance mutations within the core and NS5B regions in hepatitis C genotypes, particularly genotype 5a, in South Africa.
    Prabdial-Sing N; Blackard JT; Puren AJ; Mahomed A; Abuelhassan W; Mahlangu J; Vermeulen M; Bowyer SM
    Antiviral Res; 2016 Mar; 127():90-8. PubMed ID: 26704023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad Spectrum Peptide Vaccine Design Against Hepatitis C Virus.
    Dewi SK; Ali S; Prasasty VD
    Curr Comput Aided Drug Des; 2019; 15(2):120-135. PubMed ID: 30280672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing.
    Walker A; Skibbe K; Steinmann E; Pfaender S; Kuntzen T; Megger DA; Groten S; Sitek B; Lauer GM; Kim AY; Pietschmann T; Allen TM; Timm J
    J Virol; 2016 Jan; 90(1):33-42. PubMed ID: 26446603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promiscuous prediction and conservancy analysis of CTL binding epitopes of HCV 3a viral proteome from Punjab Pakistan: an in silico approach.
    Shehzadi A; Ur Rehman S; Idrees M
    Virol J; 2011 Feb; 8():55. PubMed ID: 21303499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and retrospective validation of T-cell epitopes in the hepatitis C virus genotype 4 proteome: an accelerated approach toward epitope-driven vaccine development.
    Abdel-Hady KM; Gutierrez AH; Terry F; Desrosiers J; De Groot AS; Azzazy HM
    Hum Vaccin Immunother; 2014; 10(8):2366-77. PubMed ID: 25424944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
    Mortier MC; Jongert E; Mettens P; Ruelle JL
    BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure.
    Rauch A; James I; Pfafferott K; Nolan D; Klenerman P; Cheng W; Mollison L; McCaughan G; Shackel N; Jeffrey GP; Baker R; Freitas E; Humphreys I; Furrer H; Günthard HF; Hirschel B; Mallal S; John M; Lucas M; Barnes E; Gaudieri S
    Hepatology; 2009 Oct; 50(4):1017-29. PubMed ID: 19670417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of epitope-based vaccine targets of HCV genotype 1 of Asian origin: a systematic in silico approach.
    Shehzadi A; Rehman SU; Husnain T
    Bioinformation; 2012; 8(20):957-62. PubMed ID: 23275687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escape from a dominant HLA-B*15-restricted CD8+ T cell response against hepatitis C virus requires compensatory mutations outside the epitope.
    Ruhl M; Chhatwal P; Strathmann H; Kuntzen T; Bankwitz D; Skibbe K; Walker A; Heinemann FM; Horn PA; Allen TM; Hoffmann D; Pietschmann T; Timm J
    J Virol; 2012 Jan; 86(2):991-1000. PubMed ID: 22072759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope.
    Neumann-Haefelin C; Timm J; Schmidt J; Kersting N; Fitzmaurice K; Oniangue-Ndza C; Kemper MN; Humphreys I; McKiernan S; Kelleher D; Lohmann V; Bowness P; Huzly D; Rosen HR; Kim AY; Lauer GM; Allen TM; Barnes E; Roggendorf M; Blum HE; Thimme R
    Hepatology; 2010 Jan; 51(1):54-62. PubMed ID: 20034048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA class I allele associations with HCV genetic variants in patients with chronic HCV genotypes 1a or 1b infection.
    Lange CM; Roomp K; Dragan A; Nattermann J; Michalk M; Spengler U; Weich V; Lengauer T; Zeuzem S; Berg T; Sarrazin C
    J Hepatol; 2010 Dec; 53(6):1022-8. PubMed ID: 20800922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of sequence variation in a dominant HLA-A*02-restricted epitope in hepatitis C virus on priming and cross-reactivity of CD8+ T cells.
    Ziegler S; Skibbe K; Walker A; Ke X; Heinemann FM; Heinold A; Mok JY; van Esch WJ; Yang D; Wölfl M; Timm J
    J Virol; 2014 Oct; 88(19):11080-90. PubMed ID: 25008925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C Virus Subtype 3a Envelope Protein 1 Binding with Human Leukocyte Antigen Class I Types of Pakistani Population: Candidate Epitopes for Synthetic Peptide Vaccine.
    Nawaz-Tipu H
    Iran J Allergy Asthma Immunol; 2015 Oct; 14(5):526-34. PubMed ID: 26742442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development.
    Lamonaca V; Missale G; Urbani S; Pilli M; Boni C; Mori C; Sette A; Massari M; Southwood S; Bertoni R; Valli A; Fiaccadori F; Ferrari C
    Hepatology; 1999 Oct; 30(4):1088-98. PubMed ID: 10498664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conserved epitopes with high HLA-I population coverage are targets of CD8
    Adikari TN; Di Giallonardo F; Leung P; Grifoni A; Sette A; Weiskopf D; Bull RA; Luciani F
    Sci Rep; 2020 Nov; 10(1):20497. PubMed ID: 33235334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes.
    Poran A; Harjanto D; Malloy M; Arieta CM; Rothenberg DA; Lenkala D; van Buuren MM; Addona TA; Rooney MS; Srinivasan L; Gaynor RB
    Genome Med; 2020 Aug; 12(1):70. PubMed ID: 32791978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.